Key result
Eltrombopag is linked to secondary erythromelalgia in idiopathic thrombocytopenic purpura.
Why the study?
Erythromelalgia can be secondary to drugs, but its association with eltrombopag in idiopathic thrombocytopenic purpura is not well characterized.
Does eltrombopag cause erythromelalgia in patients with idiopathic thrombocytopenic purpura?
Case Report
Does eltrombopag cause erythromelalgia in patients with idiopathic thrombocytopenic purpura?
Eltrombopag may be associated with erythromelalgia, a syndrome characterized by bilateral redness, heat, and paroxysmal burning pain.
Answers are grounded in this paper and cite their sources.
May warrant monitoring for erythromelalgia in eltrombopag-treated ITP; hypothesis-generating and leaves causality open.
Erythromelalgia is a recurrent and paroxysmal syndrome characterized by the clinical triad of bilateral redness, heat, and paroxysmal burning pain, mostly localized on the feet. This disorder can be primary, as a consequence of mutations in the genes encoding the voltage gated sodium channels. It can also be secondary to an underlying disease or drugs. Its pathophysiology involves either an abnormal microvascular arteriovenous shunting together with a decreased nutritional blood flow responsible for the pain , and/or a state of increase blood viscosity.
No takes yet. Share an insight, caveat, or question.
Perez et al. (2021) conducted a case report in Idiopathic thrombocytopenic purpura with erythromelalgia. Eltrombopag was evaluated. Erythromelalgia can occur as a secondary syndrome associated with eltrombopag use in patients with idiopathic thrombocytopenic purpura.
Synapse has enriched 10 related papers. Consider them for comparative context: